Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991081 · ClinicalTrials.gov registry record · Phase 4
Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00991081: Completed Phase 4 study, sponsored by Stanford University.
NCT00991081 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 36 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991081, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessation inpatients receiving medication that is matched to individual genotypes associated with increased efficacy for bupropion or nicotine replacement therapy.
Primary Outcome
Participants reporting continuous tobacco-use abstinence 12 weeks after their Target Quit Date, whose salivary cotinine levels confirmed their abstinence, were counted as "abstinent." All others were recorded as not abstinent.
Interventions
- BEHAVIORAL Counseling
- BEHAVIORAL Self-help guide
- DRUG Pharmacotherapy
- BEHAVIORAL Genetic feedback, verbal
- BEHAVIORAL Genetic feedback, printed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
What the finished NCT00991081 record still lists
NCT00991081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Counseling is the first listed.
NCT00991081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00991081 about?
NCT00991081 is a clinical study titled "Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.". The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessation inpatients receiving medication that is matched to individual genotypes associated with increased ...
What is the current status of trial NCT00991081?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2009-07. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00991081?
The interventions under investigation include: Counseling (BEHAVIORAL), Self-help guide (BEHAVIORAL), Pharmacotherapy (DRUG), Genetic feedback, verbal (BEHAVIORAL), Genetic feedback, printed (BEHAVIORAL).
Who is sponsoring clinical trial NCT00991081?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00991081's enrollment target sits among peer trials
36 1490th of 2000 higher than 495 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia